Volume 10, Issue 3 (17 2011)
ijdld 2011, 10(3): 291-298 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
اثربخشی ریپاگلیناید (Novo Norm, Novo Nordisk) در درمان دیابت ملیتوس پس از پیوند کلیه. ijdld 2011; 10 (3) :291-298
URL: http://ijdld.tums.ac.ir/article-1-122-en.html
URL: http://ijdld.tums.ac.ir/article-1-122-en.html
Abstract: (10063 Views)
This article has no abstract.
Type of Study: Research |
Subject:
General
Received: 2010/09/19 | Accepted: 2011/01/7 | Published: 2013/10/22
Received: 2010/09/19 | Accepted: 2011/01/7 | Published: 2013/10/22
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
